Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2020-12-01
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care
NCT01003834
Home-Based Program to Help Parents of Drug Abusing Adolescents
NCT01591239
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
NCT02191605
Primary Connections for Youth and Families
NCT05964010
Screening to Augment Referral to Treatment- Project START
NCT01539525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While a pilot RCT was originally planned, the study experienced significant delays and recruitment challenges due to the COVID-19 pandemic. Therefore, after review by the DSMB and study sponsor, the decision was made to eliminate the randomization and assign all participants to the intervention condition to evaluate feasibility and acceptability of the intervention. Total enrollment was N = 14. Four participants were assigned to the control condition prior to elimination of randomization. The remaining 10 participants were assigned to the intervention condition. Primary study outcomes were feasibility and acceptability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
e-screening & brief intervention (e-SBI)
A two-session (20 minutes each) computer-delivered screening and brief motivational intervention targeting alcohol and drug use. Computerized screening is conducted using the ASSIST. Session 1 of the BI includes personalized feedback, readiness to change interventions, and goal setting around substance use. Session 2 will contain motivational content reinforcing engagement in home visiting and information around other challenges mothers may experience including tobacco use, postpartum depression, and intimate partner violence.
e-screening & brief intervention (e-SBI)
Computer-delivered screening and brief motivational intervention targeting alcohol and drug use + goal-setting and content reinforcement
Control
The control group will receive a similar 2-session brief motivational intervention. Session 1 focuses on nutrition and healthy eating, session 2 focuses on exercising while pregnant or in the postpartum period.
Control e-SBI
Computer-delivered screening and brief motivational intervention targeting healthy eating and exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-screening & brief intervention (e-SBI)
Computer-delivered screening and brief motivational intervention targeting alcohol and drug use + goal-setting and content reinforcement
Control e-SBI
Computer-delivered screening and brief motivational intervention targeting healthy eating and exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older,
* pregnant or up to 3 months postpartum,
* newly enrolling in home visiting with a participating home visitor,
* not currently attending substance use treatment
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
The National Center on Addiction and Substance Abuse at Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Dauber, PhD
Role: PRINCIPAL_INVESTIGATOR
Partnership to End Addiction (formerly CASAColumbia)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Partnership to End Addiction - 485
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HELP 2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.